High-sensitivity troponin T as a marker to predict cardiotoxicity in breast cancer patients with adjuvant trastuzumab therapy

The humanized monoclonal antibody trastuzumab has been in routine use for chemotherapy for human epidermal growth factor receptor II (HER2)-positive breast cancer. A major adverse effect of trastuzumab is cardiotoxicity. Well-established biomarkers or echocardiographic parameters to predict trastuzu...

Descripción completa

Detalles Bibliográficos
Autores principales: Katsurada, Kenichi, Ichida, Masaru, Sakuragi, Masako, Takehara, Megumi, Hozumi, Yasuo, Kario, Kazuomi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216824/
https://www.ncbi.nlm.nih.gov/pubmed/25392790
http://dx.doi.org/10.1186/2193-1801-3-620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216824/
https://www.ncbi.nlm.nih.gov/pubmed/25392790
http://dx.doi.org/10.1186/2193-1801-3-620

Ejemplares similares